The FDA approved two Ziihera regimens as first-line treatment for HER2-positive advanced gastroesophageal cancer, plus two companion diagnostic tests.
Two New Drug Combinations Win Approval as the First Treatment for an Aggressive Stomach and Esophageal Cancer
by | Aug 26, 2026 | Uncategorized | 0 comments
Recent Comments